Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

Erstveröffentlichung

2019

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Ottmann, Oliver G.

Mueller-Tidow, Carsten

Kraemer, Alwin

Schlenk, Richard Friedrich

Luebbert, Michael

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

British Journal of Haematology ; 184 (2019), 6. - S. 1017-1020. - ISSN 0007-1048. - eISSN 1365-2141

Link to publication

https://dx.doi.org/10.1111/bjh.15204

Funding information

Boehringer Ingelheim

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record